Conferece report: Data from the RELIEF study show improved outcomes with FreeStyle® Libre System

This French retrospective study (33,203 people with type 1, and 40,955 people with type 2 diabetes) found that this continuous glucose monitoring device reduced annual DKA rates by 52% and 47% for people with type 1 and type 2 diabetes respectively.


Biospace Inc.